| scholarly article | Q13442814 |
| P2093 | author name string | Hui Xu | |
| Athena M Cherry | |||
| Mark A Kay | |||
| Anja Ehrhardt | |||
| Jeffrey A Engler | |||
| P433 | issue | 11 | |
| P304 | page(s) | 1077-1094 | |
| P577 | publication date | 2006-11-01 | |
| P1433 | published in | Human Gene Therapy | Q15757580 |
| P1476 | title | Molecular analysis of chromosomal rearrangements in mammalian cells after phiC31-mediated integration | |
| P478 | volume | 17 |
| Q33842218 | A method for producing transgenic cells using a multi-integrase system on a human artificial chromosome vector |
| Q34140505 | A molecularly defined duplication set for the X chromosome of Drosophila melanogaster |
| Q89076163 | A novel λ integrase-mediated seamless vector transgenesis platform for therapeutic protein expression |
| Q24630047 | A transposon and transposase system for human application |
| Q39798637 | A versatile nonviral vector system for tetracycline-dependent one-step conditional induction of transgene expression |
| Q45866460 | Active integration: new strategies for transgenesis. |
| Q34025078 | Biosafety assessment of site-directed transgene integration in human umbilical cord-lining cells |
| Q39948476 | Cell type differences in activity of the Streptomyces bacteriophage phiC31 integrase |
| Q37677605 | Delivering the goods: viral and non-viral gene therapy systems and the inherent limits on cargo DNA and internal sequences |
| Q36698269 | Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy |
| Q26995224 | Expanding the scope of site-specific recombinases for genetic and metabolic engineering |
| Q38829627 | Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy |
| Q34320340 | Generation of induced pluripotent stem cells using site-specific integration with phage integrase |
| Q33794201 | Hybrid lentivirus-phiC31-int-NLS vector allows site-specific recombination in murine and human cells but induces DNA damage. |
| Q28750796 | Impact of hydrodynamic injection and phiC31 integrase on tumor latency in a mouse model of MYC-induced hepatocellular carcinoma |
| Q37608748 | Improved site-specific recombinase-based method to produce selectable marker- and vector-backbone-free transgenic cells. |
| Q37684882 | Intragenic integration in DLC1 sustains factor VIII expression in primary human cells without insertional oncogenicity |
| Q34283639 | Kinetics and longevity of ΦC31 integrase in mouse liver and cultured cells |
| Q38892183 | Long-term and efficient expression of human β-globin gene in a hematopoietic cell line using a new site-specific integrating non-viral system |
| Q38585848 | Manipulating piggyBac transposon chromosomal integration site selection in human cells |
| Q34222706 | MiMIC: a highly versatile transposon insertion resource for engineering Drosophila melanogaster genes |
| Q37746102 | Nanoparticles for retinal gene therapy |
| Q37872790 | Non-viral episomal modification of cells using S/MAR elements |
| Q33575791 | Optimization of Streptomyces bacteriophage phi C31 integrase system to prevent post integrative gene silencing in pulmonary type II cells |
| Q38867994 | Per aspera ad astra: When harmful chromosomal translocations become a plus value in genetic evolution. Lessons from Saccharomyces cerevisiae |
| Q33426087 | PhiC31 integrase induces a DNA damage response and chromosomal rearrangements in human adult fibroblasts |
| Q44482310 | PhiC31 integrase interacts with TTRAP and inhibits NFkappaB activation |
| Q39052129 | PhiC31 integrase-mediated genomic integration and stable gene expression in the mouse mammary gland after gene electrotransfer |
| Q36187534 | Predicting preferential DNA vector insertion sites: implications for functional genomics and gene therapy |
| Q36740084 | Regulated gene insertion by steroid-induced PhiC31 integrase |
| Q37001385 | Scalable human ES culture for therapeutic use: propagation, differentiation, genetic modification and regulatory issues |
| Q37824972 | Serine recombinases as tools for genome engineering. |
| Q40032495 | Site-specific recombination in Schizosaccharomyces pombe and systematic assembly of a 400kb transgene array in mammalian cells using the integrase of Streptomyces phage phiBT1. |
| Q40037805 | Site-specific transgene integration in the human genome catalyzed by phiBT1 phage integrase |
| Q37209562 | Targeted gene insertion for molecular medicine |
| Q35224339 | Targeted plasmid integration into the human genome by an engineered zinc-finger recombinase |
| Q24633847 | The Sleeping Beauty transposon system: a non-viral vector for gene therapy |
| Q37817511 | The expanding universe of transposon technologies for gene and cell engineering. |
| Q28242655 | The therapeutic potential of ΦC31 integrase as a gene therapy system |
| Q34127579 | Translating Sleeping Beauty transposition into cellular therapies: victories and challenges |
| Q42102618 | Unsuccessful attempt at gene-editing by homologous recombination in the zebrafish germ line using the approach of "Rong and Golic". |
| Q38646228 | Utilization of Site-Specific Recombination in Biopharmaceutical Production |
| Q37945189 | Viral hybrid vectors for somatic integration - are they the better solution? |
Search more.